Lamotrigine (Girotec, AURO Lamotrigine, Girotec-d, Zesiton, Lamidus Odt)
Lamotrigine
Aurogen South Africa (Pty) Ltd
Registration
- Applicant
- Aurogen South Africa (Pty) Ltd
- Registrations
- 22
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Girotec 25 MG EACH TABLET CONTAINS LAMOTRIGINE 25,0 mg | 25 mg | 43004743/2.5/0047 | Registered | S3 | None |
| Girotec 50 MG EACH TABLET CONTAINS LAMOTRIGINE 50,0 mg | 50 mg | 43004843/2.5/0048 | Registered | S3 | None |
| Girotec 100 MG EACH TABLET CONTAINS LAMOTRIGINE 100,0 mg | 100 mg | 43004943/2.5/0049 | Registered | S3 | None |
| Girotec 200 MG EACH TABLET CONTAINS LAMOTRIGINE 200,0 mg | 200 mg | 43005043/2.5/0050 | Registered | S3 | None |
| AURO lamotrigine tablets 25 MG EACH TABLET CONTAINS LAMOTRIGINE 25,0 mg | 25 mgTablets | 43005143/2.5/0051 | Registered | S3 | None |
| AURO lamotrigine tablets 100 MG EACH TABLET CONTAINS LAMOTRIGINE 100,0 mg | 100 mgTablets | 43005343/2.5/0053 | Registered | S3 | None |
| AURO lamotrigine tablets 200 MG EACH TABLET CONTAINS LAMOTRIGINE 200,0 mg | 200 mgTablets | 43005443/2.5/0054 | Registered | S3 | None |
| Girotec-d 5 MG EACH TABLET CONTAINS LAMOTRIGINE 5,0 mg | 5 mg | 45062745/2.5/0627 | Registered | S3 | None |
| Girotec-d 25 MG EACH TABLET CONTAINS LAMOTRIGINE 25,0 mg | 25 mg | 45062845/2.5/0628 | Registered | S3 | None |
| Girotec-d 50 MG EACH TABLET CONTAINS LAMOTRIGINE 50,0 mg | 50 mg | 45062945/2.5/0629 | Registered | S3 | None |
| Girotec-d 100 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 100,0 mg | 100 mgTablet | 45063045/2.5/0630 | Registered | S3 | None |
| Girotec-d 200 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 200,0 mg | 200 mgTablet | 45063145/2.5/0631 | Registered | S3 | None |
| Zesiton 5 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 5,0 mg | 5 mgTablet | 45063245/2.5/0632 | Registered | S3 | None |
| Zesiton 25 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 25,0 mg | 25 mgTablet | 45063345/2.5/0633 | Registered | S3 | None |
| Zesiton 50 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 50,0 mg | 50 mgTablet | 45063445/2.5/0634 | Registered | S3 | None |
| Zesiton 100 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 100,0 mg | 100 mgTablet | 45063545/2.5/0635 | Registered | S3 | None |
| Zesiton 200 MG tablet EACH TABLET CONTAINS LAMOTRIGINE 200,0 mg | 200 mgTablet | 45063645/2.5/0636 | Registered | S3 | None |
| Lamidus 5 MG odt EACH TABLET CONTAINS LAMOTRIGINE 5,0 mg | 5 mg | 45063745/2.5/0637 | Registered | S3 | None |
| Lamidus 25 MG odt EACH TABLET CONTAINS LAMOTRIGINE 25,0 mg | 25 mg | 45063845/2.5/0638 | Registered | S3 | None |
| Lamidus 50 MG odt EACH TABLET CONTAINS LAMOTRIGINE 50,0 mg | 50 mg | 45063945/2.5/0639 | Registered | S3 | None |
| Lamidus 100 MG odt EACH TABLET CONTAINS LAMOTRIGINE 100,0 mg | 100 mg | 45064045/2.5/0640 | Registered | S3 | None |
| Lamidus 200 MG odt EACH TABLET CONTAINS LAMOTRIGINE 200,0 mg | 200 mg | 45064145/2.5/0641 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Lamotrigine
S3: Lamotrigine
Consolidated Schedules 06 July 2026, line 3874
Pharmacological class: Anticonvulsants, including anti-epileptics. (class 2.5)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
Drag to rotate. Structure from PubChem CID 3878.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.